Inogen juices clinician sales
By HME News Staff
Updated 10:27 AM CDT, Tue September 21, 2021
GOLETA, Cailf. – Inogen has announced an agreement with Ashfield Healthcare to enhance its go-to-market capabilities.
Per the agreement, Ashfield will add about 20 dedicated sales representatives to Inogen’s prescriber sales organization and provide the company access to its proprietary insights and data, including the specialized health care intelligence platform Gravity.ai, to support growth and drive performance in the clinician sales channel.
“Forming this relationship marks an important milestone in our strategic plan of improving market penetration for portable oxygen concentrators (POCs) with one of the most critical constituents, the clinicians,” said Nabil Shabshab, CEO and President. “By enhancing our coverage of select clinicians and increasing our collaboration with health care prescribers overall, we will raise awareness of the importance of the POC’s role in oxygen therapy and of Inogen’s leading offerings. We believe this will further enhance our ability to better serve oxygen therapy patients right at the start of their diagnosis and ongoing to maximize the impact we can deliver.”
Ashfield Healthcare, part of UDG Healthcare, an integrated health care services partner, offering services across strategic consulting, benchmarking, commercialization, customer engagement, events, marketing and communications. Its clients include top 30 global pharmaceutical companies.
Comments